Advertisement
Salem Radio Network News Friday, November 24, 2017

Health

U.S. FDA approves AstraZeneca’s asthma drug

(Reuters) – Anglo-Swedish pharmaceutical firm AstraZeneca Plc on Tuesday said the U.S. Food and Drug Administration approved its drug benralizumab, as an add-on treatment for patients with severe asthma aged 12 years and older.

The asthma drug will be marketed under the name Fasenra in the United States.

Fasenra is under regulatory review in the EU, Japan and several other countries, the company said.

Previous
Next
AdvertisementAdvertise with Us
Advertisement
Advertisement

Editorial Cartoons

View More » 1510950605502971raZJ2C9TkY

Gary Varvel
Fri, Nov 17, 2017

Advertisement
Advertisement
Advertisement
X CLOSE